SCHEMBL4285948

SCHEMBL4285948

CN(CCN)CCCCN

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.83
NFKB1 P19838 1/20 0.41
DNM1 Q05193 8/20 0.39
CA12 O43570 2/20 0.39
CA1 P00915 2/20 0.39
CA2 P00918 2/20 0.39
CA3 P07451 2/20 0.39
CA4 P22748 2/20 0.39
CA6 P23280 2/20 0.39
CA5A P35218 2/20 0.39
CA7 P43166 2/20 0.39
CA9 Q16790 2/20 0.39
CA14 Q9ULX7 2/20 0.39
CA5B Q9Y2D0 2/20 0.39
TSHR P16473 2/20 0.39
LMNA P02545 1/20 0.39
BLM P54132 1/20 0.39
CARM1 Q86X55 1/20 0.38
PRMT6 Q96LA8 1/20 0.38
PRMT8 Q9NR22 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24196749 0.97 CHRM2 (0.89) CHRM2NFKB1DNM1CA12CA1
SCHEMBL24770601 0.97 CHRM2 (0.89) CHRM2NFKB1DNM1CA12CA1
SCHEMBL2399328 0.94 CHRM2 (0.94) CHRM2NFKB1DNM1CA12CA1
SCHEMBL5603309 0.94 CHRM2 (0.94) CHRM2NFKB1DNM1CA12CA1
SCHEMBL11434663 0.91 CHRM2 (0.68) CHRM2NFKB1DNM1CA12CA1
SCHEMBL2400821 0.91 CHRM2 (0.88) CHRM2NFKB1DNM1CA12CA1
SCHEMBL17428467 0.91 CHRM2 (1.00) CHRM2NFKB1DNM1CA12CA1
SCHEMBL6755328 0.91 CHRM2 (1.00) CHRM2NFKB1DNM1CA12CA1
SCHEMBL902505 0.91
SCHEMBL19941957 0.88 CHRM2 (0.65) CHRM2NFKB1DNM1CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2300010-B1 PYRAZINE DERIVATIVES AS EPITHELIAL SODIUM CHANNEL BLOCKERS NOVARTIS AG (CH) 2015-03-04 EP disclosed
US-8236808-B2 Pyrazine derivatives as ENAC blockers NOVARTIS AG (CH) 2012-08-07 US disclosed
WO-2009150137-A2 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2009-12-17 WO disclosed